GlassScriptPhysician profile
Bryan P Payne
NPI 1427463280
$31,862.95
in general payments reported to CMS, 2019-2025
10 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $941 · 2020: $6,882 · 2021: $3,000 · 2022: $1,701 · 2023: $509 · 2024: $7,267 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Travel and Lodging: $2,010 · Food and Beverage: $1,891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,437.50 |
| Travel and Lodging | $2,010.02 |
| Food and Beverage | $1,890.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $17,986.30 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Intuitive Surgical, INC. | $12,137.89 | 2019-2025 | Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $1,064.36 | 2022 | |
| Sanara Medtech INC. | $270.99 | 2024-2025 | Celleraterx, Celleraterx |
| Acera Surgical, INC. | $112.57 | 2022 | |
| Phathom Pharmaceuticals, INC. | $102.59 | 2025 | Voquezna |
| Merit Medical Systems INC | $89.19 | 2024 | |
| Integra Lifesciences Corporation | $53.62 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $26.83 | 2025 | Pico, Renasys Touch |
| Portola Pharmaceuticals, LLC | $18.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.